Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders
Recruiting
Observational Study
Tendinopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 99
Sex
Any
Study type
Observational
Participants needed
84 (estimated)
Sponsor
TRB Chemedica AG · Industry
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
PMCF study to further substantiate the effectiveness and safety of OSTENIL® TENDON in the overall as well as indication-specific treatment of pain and restricted mobility in four different tendon disorders (patella tendon, peroneal tendon, medial epicondylus humeri and iliotibial band) in a real-life clinical setting when used according to the instructions for use.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Patient aged between 18 and 99 years
* Diagnosis of symptomatic tendinopathy (patella tendon, peroneal tendon, medial epicondylus humeri or iliotibial band)
* Physician's recommendation to use OSTENIL® TENDON prior to recruitment
* Signed informed consent
Exclusion Criteria:
…
Inclusion Criteria:
* Patient aged between 18 and 99 years
* Diagnosis of symptomatic tendinopathy (patella tendon, peroneal tendon, medial epicondylus humeri or iliotibial band)
* Physician's recommendation to use OSTENIL® TENDON prior to recruitment
* Signed informed consent
Exclusion Criteria:
* Presence of any contra-indication or precautionary condition listed in the instructions for use, i.e.,
* Ascertained hypersensitivity to any of the OSTENIL® TENDON constituents
* Known pregnancy or breast feeding
* Acute trauma
* Use of the following treatments (the given time intervals refer to the date of inclusion):
* Local\* OSTENIL® TENDON or other hyaluronic acid (HA) treatment within the last 6 months
* Local\* platelet-rich plasma (PRP) treatment within the last 3 months
* Local\* corticosteroid treatment (without time restriction)
* Local\* extracorporeal shock wave therapy (ESWT) within the last 4 weeks
* Local\* phytotherapy (e.g., Traumeel®) within the last 4 weeks
* Local\* surgical intervention (without time restriction)
* Systemic corticosteroid treatment within the last 4 weeks
* Repeated use of non-steroidal anti-inflammatory drugs (NSAID) and/or other analgesics within the last week
* Physiotherapy (therapeutic exercises and physical therapy), ortheses, transcutaneous electrical nerve stimulation (TENS) or acupuncture within the last week
* Diagnosis of chronic inflammatory disease (e.g. rheumatoid arthritis, Bechterew disease, Crohn's disease, etc.) prior to inclusion
* Participation in a clinical investigation within the last 6 months
* Vulnerable patient (individual who is unable to fully understand all aspects of the study that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response \[including persons needing legally designated representatives, illiterate persons or persons with insufficient knowledge of local language\])
(\* local refers to the treatment of the study-relevant tendon)
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.